-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
4-Bromo-N-methyl-2-pyrimidinamine is a chemical compound that is commonly used in the production of a range of chemicals and pharmaceuticals.
It is an important building block in the synthesis of a variety of downstream products, and its demand is increasing globally due to its diverse range of applications.
Upstream and Downstream Products
The upstream and downstream products of 4-bromo-N-methyl-2-pyrimidinamine can be classified into several categories.
The upstream products include the raw materials required for its production, such as methyl iodide, sodium hydroxide, and potassium hydroxide.
The downstream products, on the other hand, are the various chemicals and pharmaceuticals that are synthesized using 4-bromo-N-methyl-2-pyrimidinamine as a precursor.
One of the most common downstream products of 4-bromo-N-methyl-2-pyrimidinamine is the antibiotic erythromycin.
Erythromycin is a macrolide antibiotic that is used to treat a variety of bacterial infections.
It is synthesized by the reaction of 4-bromo-N-methyl-2-pyrimidinamine with a series of other chemicals to form the erythromycin precursor, which is subsequently transformed into the final product through a series of chemical reactions.
Another important downstream product of 4-bromo-N-methyl-2-pyrimidinamine is the anti-cancer drug, cytarabine.
Cytarabine is used to treat a range of leukemias and lymphomas, and is synthesized by reacting 4-bromo-N-methyl-2-pyrimidinamine with a series of other chemicals.
4-Bromo-N-methyl-2-pyrimidinamine is also used in the synthesis of anti-malarial drugs such as chloroquine and quinine.
These drugs are used to treat malaria, a parasitic infection that affects millions of people worldwide each year.
In addition to its use in the synthesis of pharmaceuticals, 4-bromo-N-methyl-2-pyrimidinamine is also used in the production of various other chemicals.
For example, it is a key intermediate in the synthesis of dyes, pigments, and other industrial chemicals.
Manufacturing Process
The manufacturing process for 4-bromo-N-methyl-2-pyrimidinamine involves several steps, including the synthesis of the raw materials, the mixing and reaction of these raw materials, and the isolation and purification of the final product.
The synthesis of the raw materials, such as methyl iodide and sodium hydroxide, is typically carried out in dedicated pilot plants or centralized facilities.
These raw materials are then transported to the main manufacturing site, where they are mixed and reacted to form the desired product.
The synthesis of 4-bromo-N-methyl-2-pyrimidinamine typically involves several steps, including the reaction of methyl iodide and sodium hydroxide to form iodomethane, the reaction of iodomethane with potassium hydroxide to form iodide, and the reaction of the resulting iodide with 2-pyrimidinecarboxaldehyde to form the final product.
The reaction mixture is then purified by a series of chromatography and crystallization steps, resulting in the production of pure 4-bromo-N-methyl-2-pyrimidinam